Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Creatine kinase: stability, inactivation, reactivation

L G Morin

    Clinical Chemistry
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    The study determined creatine kinase isoenzyme stability, finding thermal factors drive irreversible inactivation in vivo. Prompt cooling and mercaptoethanol addition are recommended for preserving specimen integrity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nonenzymic glycation of human immunoglobulins does not impair their immunoreactivity.

    Clinical chemistry·1989
    Same author

    Capacity related characteristics of Glyco-Gel affinity chromatographic support.

    Clinical biochemistry·1988
    Same author

    Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.

    Clinical chemistry·1987
    Same author

    Nonenzymatic glycation of immunoglobulins does not impair antigen-antibody binding.

    Clinical chemistry·1987
    Same author

    Improved separation of fetal hemoglobin by mini-column chromatography.

    Clinical chemistry·1987
    Same author

    A "column-batch" method for separating MB and LD1 in a single fraction.

    Clinical chemistry·1983
    Same journal

    Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

    Clinical chemistry·2026
    Same journal

    Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

    Clinical chemistry·2026
    Same journal

    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

    Clinical chemistry·2026
    Same journal

    TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

    Clinical chemistry·2026
    Same journal

    Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

    Clinical chemistry·2026
    Same journal

    Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

    Clinical chemistry·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Enzymology
    • Clinical Chemistry

    Background:

    • Creatine kinase (CK) isoenzymes are crucial biomarkers.
    • Understanding CK isoenzyme stability is vital for accurate clinical diagnostics.
    • In vitro stability data can inform in vivo inactivation mechanisms.

    Purpose of the Study:

    • To determine in vitro biological half-lives of creatine kinase isoenzymes at different temperatures.
    • To elucidate the mechanisms of reversible and irreversible isoenzyme inactivation.
    • To establish optimal conditions for specimen storage and handling.

    Main Methods:

    • In vitro determination of decay constants for CK isoenzymes across various temperatures.
    • Assessment of factors influencing isoenzyme inactivation, including temperature, oxidation-reduction, proteins, urate, catecholamines, dilution, and thiols.

    Related Experiment Videos

  • Evaluation of mercaptoethanol as a stabilizing agent for CK isoenzyme MB.
  • Main Results:

    • In vitro half-lives at 37°C align with in vivo data, suggesting thermal inactivation is primary in vivo.
    • Reversible inactivation is linked to oxidation-reduction processes.
    • Proteins and specific inactivators stabilize isoenzymes; dilution and thiols promote reactivation.
    • Mercaptoethanol is optimal for CK isoenzyme MB storage and reactivation.
    • CK isoenzyme MB exhibits sensitivity to light and freeze-thawing.

    Conclusions:

    • In vivo irreversible inactivation of creatine kinase isoenzymes is predominantly driven by thermal factors.
    • Specimen handling protocols including prompt cooling, addition of mercaptoethanol, refrigeration, and avoidance of light/freezing are recommended.
    • A proposed inactivation model involving active, denatured, oxidized, and insulated monomers explains observed phenomena.